Teva Pharmaceutical Industries (TEVJF) Net Income - Minority (2016 - 2025)
Historic Net Income - Minority for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to -$4.0 million.
- Teva Pharmaceutical Industries' Net Income - Minority rose 4285.71% to -$4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.0 million, marking a year-over-year increase of 4285.71%. This contributed to the annual value of -$4.0 million for FY2025, which is 4285.71% up from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Net Income - Minority stood at -$4.0 million for Q4 2025, which was up 4285.71% from -$4.0 million recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Net Income - Minority registered a high of -$4.0 million during Q3 2025, and its lowest value of -$987.0 million during Q2 2021.
- In the last 5 years, Teva Pharmaceutical Industries' Net Income - Minority had a median value of -$638.0 million in 2023 and averaged -$529.5 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Net Income - Minority crashed by 154.32% in 2021 and then surged by 9887.1% in 2024.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Net Income - Minority stood at -$966.0 million in 2021, then increased by 17.81% to -$794.0 million in 2022, then increased by 21.91% to -$620.0 million in 2023, then surged by 98.87% to -$7.0 million in 2024, then soared by 42.86% to -$4.0 million in 2025.
- Its Net Income - Minority was -$4.0 million in Q4 2025, compared to -$4.0 million in Q3 2025 and -$7.0 million in Q2 2025.